CoChat

Ameliorative Effect of Annona muricata (Graviola) Extract on Hyperglycemia Induced Hepatic Damage in Type 2 Diabetic Mice

Open access

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Annona muricata (AM) is evergreen plant of the Annonaceae family and known to have anticancer and antidiabetic effects. However, anti-diabetic mechanisms of AM extracts (AME) associated with hepatic glucose regulation and lipid metabolism remain unclear. In this study, we investigated the protective effect of AME extracted on hepatic damage in diabetic mice. Diabetes was induced by a high-fat diet with two-times streptozotocin (STZ) injection (60 mg/kg BW) in C57BL/6 male mice. The diabetic mice were daily administered with AME (50 or 100 mg/kg BW) by gavage for 9 weeks. Biomarkers related to energy metabolism and insulin signaling were examined to identify the effect of AME on hyperglycemia induced hepatic damage. AME supplementation reduced levels of FBG, HbA1c, HOMA-IR and hepatic lipid profiles as well as enhanced insulin signaling by increased the protein levels of IRS-1 accompanied GLUT2 in diabetic mice. Especially low dose of AME showed the beneficial effect of reducing oxidative stress (4-HNE, protein carbonyls, Nrf2, NQO1) and improved hepatic morphology demonstrated by lipid droplets along with upregulation of lipophagy (pAMPK, p-mTOR/mTOR, LC3-2/LC3-1) in diabetic mice. Moreover, AME supplementation ameliorated hepatic lipid metabolism (FAS, SREBP1c, C/EBPα, PPARγ, CPT1A, PPARα) and energy metabolism (pAMPK, PGC1α) in diabetic mice. Taken together, this study suggested that AME could be helpful to prevent hepatic abnormality by regulation of insulin signaling associated with energy metabolism and autophagy in diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antiox10101546

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 HPLC chromatogram of AME. (1) Rutin (Rt, 4.79), (2) Kaempferol-3-O-rutinoside (Rt, 5.04), (3) Quercetin (Rt, 6.03), (4) Kaempferol (Rt, 6.55), (5) Muricoreacin (Rt, 8.74), (6) Annonacin (Rt, 10.39) (7) Annonacinone (Rt, 10.59).
Figure 1 HPLC chromatogram of AME. (1) Rutin (Rt, 4.79), (2) Kaempferol-3-O-rutinoside (Rt, 5.04), (3) Quercetin (Rt, 6.03), (4) Kaempferol (Rt, 6.55), (5) Muricoreacin (Rt, 8.74), (6) Annonacin (Rt, 10.39) (7) Annonacinone (Rt, 10.59).CC BY · PubMed Central
Figure 2 Effects of AME on (A) fasting blood glucose and (B) hemoglobin A1c (HbA1c) levels in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 10~11 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.
Figure 2 Effects of AME on (A) fasting blood glucose and (B) hemoglobin A1c (HbA1c) levels in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 10~11 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.CC BY · PubMed Central
Figure 3 Effect of AME on glucose intolerance and insulin resistance, (A) OGTT, (B) OGTT AUC, and (C) plasma insulinT2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 10~11 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.
Figure 3 Effect of AME on glucose intolerance and insulin resistance, (A) OGTT, (B) OGTT AUC, and (C) plasma insulinT2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 10~11 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.CC BY · PubMed Central
Figure 4 Effect of AME on hepatic damage related markers, (A) aspartate aminotransferase (AST) and (B) alanine aminotransferase (ALT) in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 10~11 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.
Figure 4 Effect of AME on hepatic damage related markers, (A) aspartate aminotransferase (AST) and (B) alanine aminotransferase (ALT) in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 10~11 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.CC BY · PubMed Central
Figure 5 Effect of AME on hepatic (A) morphology (×200) and (B) hepatic TG and TC levels in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 4 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.
Figure 5 Effect of AME on hepatic (A) morphology (×200) and (B) hepatic TG and TC levels in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 4 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.CC BY · PubMed Central
Figure 6 Effect of AME on insulin signaling in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 6 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.
Figure 6 Effect of AME on insulin signaling in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 6 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.CC BY · PubMed Central
Figure 7 Effect of AME on (A) 4-HNE, (B) protein carbonyls, and (C) oxidative stress related markers in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 6 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.
Figure 7 Effect of AME on (A) 4-HNE, (B) protein carbonyls, and (C) oxidative stress related markers in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 6 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.CC BY · PubMed Central
Figure 8 Effect of AME on energy metabolism in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 6 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.
Figure 8 Effect of AME on energy metabolism in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 6 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.CC BY · PubMed Central
Figure 9 Effect of AME on autophagy in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 6 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.
Figure 9 Effect of AME on autophagy in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 6 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.CC BY · PubMed Central
Figure 10 Effect of AME on lipid metabolism, (A) lipogenesis related markers (B) β-oxidation related markers, in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 6 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.
Figure 10 Effect of AME on lipid metabolism, (A) lipogenesis related markers (B) β-oxidation related markers, in T2DM mice All values are reported as mean and SEM. Values with the different superscript letter were significantly different (p < 0.05; ANOVA with post-hoc Duncan’s multiple range test). n = 6 mice in each group CON, normal control group (negative control); DMC, type 2 diabetic control group (positive control); LAM, diabetic group supplemented with low dosage (50 mg/kg BW) of AME; HAM, diabetic group supplemented with high dosage (100 mg/kg BW) of AME.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

15 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 1

  1. Adeyemi, 2012, Effects of Annona muricata (Linn) on the morphology of pancreatic islet cells of experimentally-induced diabetic wistar rats, Internet J. Altern. Med., 5, 2209164

Cited by

See all 37

Metadata

Authors
Son, Y., Lee, H., Son, S.-Y., Lee, C.-H., Kim, S.-Y., & Lim, Y.
Affiliations
  • Kyung Hee University (KR)
  • Konkuk University (KR)
  • Gachon University (KR)
Corresponding author
Lim, Yunsook
Venue
Antioxidants
Publisher
MDPI AG
Published
2021-09-29
Volume
10
Issue
10
Pages
1546
ISSN
2076-3921 (ISSN-L)
OpenAlex
W3203289121
Cited by
35
References
45
Citations by year
2026: 3 · 2025: 8 · 2024: 10 · 2023: 10 · 2022: 4
FWCI
4.48
Type
journal article
Language
en
Open access
Locations
  • Antioxidants (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Ministry of Education, Science and Technology (2021R1A2C2007708)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Traditional and Medicinal Uses of Annonaceae
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords
Annona muricata, type 2 diabetes, hyperglycemia, liver injury, insulin resistance, insulin signaling, IRS-1, GLUT2, oxidative stress, Nrf2, lipophagy, autophagy, hepatic lipid metabolism, energy metabolism, AMPK, PGC-1α, PPARγ, SREBP-1c, C/EBPα, CPT1A, streptozotocin-induced diabetes, high-fat diet, lipid droplets

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.